These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4210686)

  • 21. Determination of HVA and 5-HIAA in ventricular CSF of patients with brain tumors.
    Porta M; Bareggi SR; Collice M; Ferrara M; Calderini G; Morselli PL
    J Neurosurg Sci; 1974; 18(3):157-63. PubMed ID: 4465414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
    Degrell I; Nagy E
    Biol Psychiatry; 1990 Apr; 27(8):891-6. PubMed ID: 1691925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid in children with afebrile and febrile convulsions.
    Habel A; Yates CM; McQueen JK; Blackwood D; Elton RA
    Neurology; 1981 Apr; 31(4):488-91. PubMed ID: 6164017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients.
    Wode-Helgodt B; Fyrö B; Gullberg B; Sedvall G
    Acta Psychiatr Scand; 1977 Aug; 56(2):129-42. PubMed ID: 899844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 26. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 27. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
    Muizelaar JP; Oberink JI
    Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid monoamine metabolites in patients with infantile spasms.
    Silverstein F; Johnston MV
    Neurology; 1984 Jan; 34(1):102-5. PubMed ID: 6197678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R; Ekstedt J; Anggård E
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis.
    Davidson D; Pullar IA; Mawdsley C; Kinloch N; Yates CM
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):741-5. PubMed ID: 925693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients.
    Fyrö B; Petterson U; Sedvall G
    Psychopharmacologia; 1975 Oct; 44(1):99-103. PubMed ID: 1105629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of dexamethasone on cerebrospinal fluid monoamine metabolites and cortisol in psychiatric patients.
    Banki CM; Arató M; Papp Z; Kurcz M
    Pharmacopsychiatria; 1983 May; 16(3):77-81. PubMed ID: 6193544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
    Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 37. Bovine spastic paralysis: cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in normal and spastic calves.
    De Ley G; De Moor A
    Am J Vet Res; 1975 Feb; 36(2):227-8. PubMed ID: 1111389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Values of serial determinations of cerebrospinal fluid metabolites of biogenic amines in various neurologic diseases].
    Spissu A; Piccardi MP; Corsini GU; Mangoni A
    Acta Neurol (Napoli); 1976; 31(5):549-57. PubMed ID: 827925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.